• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.45% Nasdaq Up 0.40%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    369.95 Down 7.78(2.06%) 4:00PM EDT
    |After Hours : 370.05 Up 0.10 (0.03%) 6:06PM EDT
    Prev Close:377.73
    Open:376.36
    Bid:366.00 x 100
    Ask:370.09 x 100
    1y Target Est:473.86
    Beta:1.50334
    Earnings Date:Aug 2 - Aug 8 (Est.)
    Day's Range:365.93 - 377.43
    52wk Range:348.96 - 605.93
    Volume:884,870
    Avg Vol (3m):951,456
    Market Cap:38.67B
    P/E (ttm):67.02
    EPS (ttm):5.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    REGNDown 2.06%38.67B
    AMGNDown 0.69%115.05B

    Key Statistics

    Forward P/E (1 yr):22.65
    P/S (ttm):9.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :11.54
    Quarterly EPS Est (Jun-16) :2.72
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.59

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback